EA201891177A1 - PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES OF LOCAL APPLICATION AND METHOD FOR ITS PREPARATION AND APPLICATION (OPTIONS) - Google Patents
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES OF LOCAL APPLICATION AND METHOD FOR ITS PREPARATION AND APPLICATION (OPTIONS)Info
- Publication number
- EA201891177A1 EA201891177A1 EA201891177A EA201891177A EA201891177A1 EA 201891177 A1 EA201891177 A1 EA 201891177A1 EA 201891177 A EA201891177 A EA 201891177A EA 201891177 A EA201891177 A EA 201891177A EA 201891177 A1 EA201891177 A1 EA 201891177A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- application
- infectious
- preparation
- treatment
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Abstract
Изобретение относится к области медицины и химико-фармацевтической промышленности. Предложена фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний в виде раствора для местного применения, характеризующаяся тем, что она содержит в качестве активного начала комбинацию Грамицидина C дигидрохлорида и цетилпиридиния хлорида, в качестве вспомогательных веществ - этанол 96%, сукралозу, глицерол, лимонную кислоту моногидрат, натрия цитрат, полисорбат, метилпарабен, пропилпарабен, ароматизатор натуральный мятный, воду очищенную. Также предложен способ ее получения и применения.The invention relates to the field of medicine and pharmaceutical industry. The proposed pharmaceutical composition for the treatment of infectious and inflammatory diseases in the form of a solution for local use, characterized in that it contains as an active principle a combination of Gramicidin C dihydrochloride and cetylpyridinium chloride, as auxiliary substances - ethanol 96%, sucralose, glycerol, citric acid monohydrate , sodium citrate, polysorbate, methylparaben, propylparaben, natural mint flavor, purified water. A method for its preparation and use is also proposed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2016125965A RU2627423C1 (en) | 2016-06-29 | 2016-06-29 | Pharmaceutical composition of local application for infectious inflammatory diseases treatment, and method for its production and application |
PCT/RU2016/000815 WO2017095266A1 (en) | 2015-12-01 | 2016-11-24 | Pharmaceutical composition for topical application for treating infectious inflammatory diseases, and method for producing and using same (variants) |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201891177A1 true EA201891177A1 (en) | 2018-10-31 |
EA039541B1 EA039541B1 (en) | 2022-02-08 |
Family
ID=59632633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201891177A EA039541B1 (en) | 2016-06-29 | 2016-11-24 | Pharmaceutical composition for topical application for treating infectious inflammatory diseases, method for production and use thereof |
Country Status (2)
Country | Link |
---|---|
EA (1) | EA039541B1 (en) |
RU (1) | RU2627423C1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2213558C1 (en) * | 2002-09-30 | 2003-10-10 | Нестерук Владимир Викторович | Antibacterial agent |
US20060024335A1 (en) * | 2004-07-29 | 2006-02-02 | Roger Stier E | Oral compositions which mask the bitter taste of a bitter-tasting agent |
DE102009008094A1 (en) * | 2009-02-09 | 2010-08-19 | Barnikol-Keuten, Doris, Dr. | In situ adhesive gel-forming preparations, in particular for topical application to moisturized skin / mucosa |
TWI632921B (en) * | 2011-10-19 | 2018-08-21 | 大塚製藥股份有限公司 | Solution for oral administration |
-
2016
- 2016-06-29 RU RU2016125965A patent/RU2627423C1/en active
- 2016-11-24 EA EA201891177A patent/EA039541B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA039541B1 (en) | 2022-02-08 |
RU2627423C1 (en) | 2017-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201592250A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of diseases | |
EA201592256A1 (en) | DERIVATIVES OF IMIDAZOPIRROLIDINONE AND THEIR APPLICATION IN THE TREATMENT OF DISEASES | |
MX368504B (en) | Amide derivatives and pharmaceutically acceptable salts thereof, preparation method therefor and medicinal application thereof. | |
EA201691151A1 (en) | CONNECTIONS FOR THE TREATMENT OF PATIENTS WITH ROS1-MUTANT CANCER CELLS | |
EA201890767A1 (en) | C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR INHIBITION OF IL-17 AND OTHER APPLICATIONS | |
EA201591751A1 (en) | TRIPEPTIDE EPOKEKETONE PROTEASE INHIBITORS | |
MX2020010300A (en) | Mono-(acid) salts of 6-aminoisoquinolines and uses thereof. | |
EA201592255A1 (en) | DERIVATIVES OF PYRAZOLOPIRROLIDIN-4-IT AS A BET INHIBITOR AND THEIR APPLICATION IN THE TREATMENT OF THE DISEASE | |
PH12016501357B1 (en) | Pharmaceutical preparation containing pyridylaminoacetic acid compound | |
EA201592254A1 (en) | DERIVATIVES OF Pyrazolopyrrolidin-4-IT and THEIR APPLICATION IN THE TREATMENT OF DISEASE | |
EA201291089A1 (en) | METHOD FOR OBTAINING PHARMACEUTICAL PREPARATIONS INTENDED FOR ORAL ADMINISTRATION, CONTAINING ONE OR MORE ACTIVE INGREDIENTS AND CONTAINING COMPOSITIONS | |
EA201792072A2 (en) | GLUTARIMIDES DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION ON THEIR BASIS, METHODS OF THEIR PRODUCTION | |
MY179605A (en) | Use of benzimidazole-proline derivatives | |
EA201691918A1 (en) | PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | |
WO2016057413A3 (en) | Inhibitors of lysine gingipain | |
PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
EA201690077A1 (en) | THERAPEUTICALLY ACTIVE DERIVATIVES OF ESTRATRIEN-THIAZOLE | |
EA201792264A1 (en) | METHODS OF TREATING INFLAMMATORY DISEASES | |
SG10201908690WA (en) | Novel method of use and compositions | |
CY1117795T1 (en) | PHARMACEUTICAL COMPOSITIONS EXCEPTION OF CITRUS SALT THAT INCLUDE | |
EA201792237A1 (en) | PHARMACEUTICAL COMPOSITIONS | |
EA201791191A1 (en) | WATER PHARMACEUTICAL COMPOSITIONS FOR LOCAL APPLICATION IN THE ORAL CAVITY CONTAINING FLURBIPROPHENE AND DEXPANTENOL | |
EA201891177A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES OF LOCAL APPLICATION AND METHOD FOR ITS PREPARATION AND APPLICATION (OPTIONS) | |
EA201891176A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES OF LOCAL APPLICATION AND METHOD FOR ITS PREPARATION AND APPLICATION | |
PL407711A1 (en) | Derivatives of N-Guanyl derivatives of 9-amino-5,11-dimethyl-5H-indolo[2,3-b]quinoline, method for obtaining them and pharmaceuticals containing them |